Department of Paediatrics, B.J. Government Medical College, Pune, India.
Ethiop J Health Sci. 2022 Nov;32(6):1203-1210. doi: 10.4314/ejhs.v32i6.18.
Thalassemia is considered as the most common single gene disorder worldwide. Preventive measures include identification of thalassemia carriers (traits) through screening, genetic counselling and prenatal diagnosis to reduce the incidence. This study aims at estimating the prevalence of carrier status detection among the extended family members of children having thalassemia major so as to use it as a screening prevention strategy with appropriate counselling.
This cross-sectional study was conducted in thalassemia unit of Pediatric Department of a tertiary care teaching hospital over a period of 18 months. Blood samples were collected from 117 extended family members (EFM) of 23 children with thalassemia major to carry out investigations such as Complete Blood Counts (CBC), Naked Eye Single Tube Red Cell Osmotic Fragility Test (NESTROFT), Reticulocyte count, High Performance Liquid Chromatography(HPLC) and serum ferritin. Reports were analysed to find out the prevalence of carriers.
Among 117 EFM, 62 (52.9%) were males while 55(47.1%) were females. Mean age distribution in this study was 16.49 years (8.5). Prevalence of thalassemia trait (carrier) was 35%. NESTROFT test was positive in 57(48.7%) participants. The binary logistic regression found only positive NESTROFT test as a predictor (adjusted OR=0.022, P=0.001) of having raised HbA2 (HbA2≥3.5 %).
Screening of thalassemia carrier by targeting extended family members of thalassemia major children could yield more carrier cases and targeted counselling could help effectively in decreasing the number of children born with thalassemia major. This strategy could be included in future plan of national prevention programme for thalassemia.
地中海贫血症被认为是全球最常见的单基因疾病。预防措施包括通过筛查、遗传咨询和产前诊断来确定地中海贫血携带者(特征),以降低发病率。本研究旨在评估地中海贫血患儿的大家庭成员中携带者检测的流行率,以便将其用作具有适当咨询的筛查预防策略。
这是一项在三级教学医院儿科地中海贫血科进行的横断面研究,历时 18 个月。从 23 名地中海贫血患儿的 117 名大家庭成员(EFM)中采集血液样本,进行全血细胞计数(CBC)、肉眼单管红细胞渗透脆性试验(NESTROFT)、网织红细胞计数、高效液相色谱法(HPLC)和血清铁蛋白等检查。分析报告以确定携带者的流行率。
在 117 名 EFM 中,62 名(52.9%)为男性,55 名(47.1%)为女性。本研究的平均年龄分布为 16.49 岁(8.5)。地中海贫血特征(携带者)的患病率为 35%。57 名(48.7%)参与者的 NESTROFT 试验阳性。二项逻辑回归发现,仅阳性 NESTROFT 试验是 HbA2 升高(HbA2≥3.5%)的预测因子(调整后的 OR=0.022,P=0.001)。
针对地中海贫血患儿的大家庭成员进行地中海贫血携带者筛查,可以发现更多的携带者病例,有针对性的咨询可以有效减少出生时患有地中海贫血的儿童数量。该策略可纳入未来的国家地中海贫血预防计划。